ArticleBioMed research international2026
Protective Effects of Donkey Milk-Derived Exosomes Against UVB-Induced Skin Photoaging via Regulation of DNA Damage and Aging-Related Pathways.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Protective Effects of Donkey Milk-Derived Exosomes Against UVB-Induced Skin Photoaging via Regulation of DNA Damage and Aging-Related Pathways.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prolonged exposure to UVB radiation accelerates skin photoaging by inducing DNA damage, promoting collagen degradation, and triggering cellular senescence. There is a growing interest in identifying effective natural interventions to prevent or mitigate these adverse effects. This study investigated the protective role and underlying mechanisms of donkey milk-derived exosomes (DM-Exos) against UVB-induced skin aging using both in vitro skin cell models and in vivo mouse models. The results demonstrated that DM-Exos significantly reduced UVB-induced cellular senescence, as evidenced by decreased β-galactosidase activity and downregulation of senescence-associated genes. DM-Exos also attenuated intracellular ROS production and reduced DNA damage markers (γ-H2AX and 8-OHdG) both in vitro and in vivo. Transcriptomic analysis further revealed that DM-Exos mitigated UVB-induced alterations in pathways related to cellular senescence, DNA damage, cell proliferation, and response to UV radiation, which were corroborated by qPCR validation of key aging-related genes. These findings underscore the potential of DM-Exos as a promising natural agent for protecting against UVB-induced skin aging and maintaining overall skin health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.